InvestorsHub Logo

TheBigTicket

12/13/18 8:41 AM

#174286 RE: XenaLives #174259

Well i will be working for Takeda come Jan 8th when the buyout of Shire closes...so i will try to get AVXL on their radar—although i doubt they will be doing any more deals in the near future after shelling out $66 Billion for Shire and going into massive debt through this acquisition.

Bourbon_on_my_cornflakes

12/13/18 10:17 AM

#174302 RE: XenaLives #174259

Agree Eisai or Tekeda are great potential partners. cover the huge Japanese aging population and Japanese docs like to prescribe drugs. plus both comapanies have a history of paying FAT prices for companies and partners they want